You are here
The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.
SBC: BIOO SCIENTIFIC CORPORATION Topic: CBD14105
Burkholderia pseudomallei and Burkholderia mallei are highly pathogenic Gram - negative bacteria and the causative agents of melioidosis and glanders, respectively. These infections, which occur in humans and other animals, are endemic is wide regions of the developing world. This Phase II SBIR project will build on the success of our Phase I work, which established methods for generating monoclon ...SBIR Phase II 2015 Department of DefenseOffice for Chemical and Biological Defense
SBC: BIOMACHINES, INC. Topic: CBD02101
In the wake of the September 11th attacks and subsequent Anthrax scares, researchers worldwide are working to expand our ability to rapidly assess what poses a terrorism threat to the public. The rapid detection of specific pathogens is required for biodSBIR Phase II 2004 Department of DefenseOffice for Chemical and Biological Defense
SBC: OMNISITE BIODIAGNOSTICS, INC. Topic: N/A
OmniSite proposes to continue Phase I effort to develop aptamer-based assays to anthrax spores and SEB for detection instruments based on ECL, FP, and FRET formats. OmniSite will compare the different assay formats to determine which of thesedemonstrates the most sensitivity and specificity, as well as being robust, cost effective, and facile. Performance characteristics of the most sensitive ...SBIR Phase II 2003 Department of DefenseOffice for Chemical and Biological Defense